🇺🇸 Spiromax Budesonide/formoterol in United States
11 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 11
Most-reported reactions
- Arthralgia — 2 reports (18.18%)
- Abdominal Pain — 1 report (9.09%)
- Angina Pectoris — 1 report (9.09%)
- Anxiety — 1 report (9.09%)
- Appendicitis — 1 report (9.09%)
- Asthma — 1 report (9.09%)
- Cardiac Failure — 1 report (9.09%)
- Cerebrovascular Accident — 1 report (9.09%)
- Covid-19 — 1 report (9.09%)
- Discomfort — 1 report (9.09%)
Other Respiratory approved in United States
Frequently asked questions
Is Spiromax Budesonide/formoterol approved in United States?
Spiromax Budesonide/formoterol does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Spiromax Budesonide/formoterol in United States?
University Medical Center Groningen is the originator. The local marketing authorisation holder may differ — check the official source linked above.